Rabia Gurses Ozden

Insider Reports History

Entity
Individual
Location
C/O Akouos, Inc., 645 Summer Street Suite 200, Boston, MA
Signature
/s/ John Rakow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rabia Gurses Ozden:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Medical Officer Common Stock 153K $744K $4.86 Feb 5, 2024 Direct
OCULAR THERAPEUTIX, INC Chief Medical Officer Stock Option (Right to Buy) 200K Feb 3, 2024 Direct
Adverum Biotechnologies, Inc. Chief Medical Officer Stock Option (Right to Buy) 44K Aug 2, 2024 Direct

Insider Reports Filed by Rabia Gurses Ozden

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADVM Adverum Biotechnologies, Inc. Aug 2, 2024 1 $0 4 Aug 6, 2024 Chief Medical Officer
ADVM Adverum Biotechnologies, Inc. Jun 17, 2024 1 $0 4 Jun 20, 2024 Chief Medical Officer
OCUL OCULAR THERAPEUTIX, INC Feb 3, 2024 3 $30.8K 4 Feb 6, 2024 Chief Medical Officer
OCUL OCULAR THERAPEUTIX, INC Jan 31, 2024 1 -$38.4K 4 Feb 2, 2024 Chief Medical Officer
OCUL OCULAR THERAPEUTIX, INC Jul 7, 2023 1 -$4.1K 4 Jul 11, 2023 Chief Medical Officer
ADVM Adverum Biotechnologies, Inc. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
OCUL OCULAR THERAPEUTIX, INC Feb 6, 2023 1 -$27.2K 4 Feb 8, 2023 Chief Medical Officer
OCUL OCULAR THERAPEUTIX, INC Jan 30, 2023 3 $0 4 Feb 1, 2023 Chief Medical Officer
OCUL OCULAR THERAPEUTIX, INC Jul 1, 2022 4 $0 4 Jul 15, 2022 Chief Medical Officer
OCUL OCULAR THERAPEUTIX, INC Jul 1, 2022 0 $0 3 Jul 11, 2022 Chief Medical Officer
ADVM Adverum Biotechnologies, Inc. Mar 17, 2022 1 $0 4 Mar 18, 2022 Director
ADVM Adverum Biotechnologies, Inc. Mar 17, 2022 0 $0 3 Mar 18, 2022 Director